Inhibitors of 5α-reductase such as finasteride, which limit androgen receptor (AR) signaling by impairing the conversion of testosterone to dihydrotestosterone, have been investigated in the context of PCa prevention (5). Here, AR is linked to posterior cortical atrophy.